Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00138294 · ClinicalTrials.gov registry record · Phase 4
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program
A Phase 4 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 29,255
- Enrollment target
NCT00138294 is a Phase 4 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 29,255 participants.
The verdict
NCT00138294, a Phase 4 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29,255 participants
- Enrollment target
Study Summary
The main purpose of this study is to learn if influenza vaccines (live attenuated and inactivated influenza vaccines), when given to school-aged children 4 to 18 years of age, can stop or lessen the influenza (flu) outbreak in the community. Another purpose is to show that vaccination of these children will significantly reduce breathing problems (in the vaccinated children and unvaccinated people they come in contact with in the community) that require a visit to the doctor for treatment. Another purpose is to continue to collect safety and flu protection information on live attenuated influenza vaccine (LAIV or FluMist) given to children. The study investigators believe that vaccination of healthy school-aged children is an effective plan for preventing many people in the community from catching the flu. Children will take part in the study for 5 to 10 months.
Interventions
- BIOLOGICAL live attenuated and inactivated influenza vaccines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29,255 participants |
| Start Date | 1998-10 |
| Est. Completion | 2010-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00138294
The ClinicalTrials.gov registry entry for NCT00138294 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 29,255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which live attenuated and inactivated influenza vaccines is the first listed.
NCT00138294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00138294 about?
NCT00138294 is a clinical study titled "Control of Epidemic Influenza Through a School-based Influenza Vaccination Program". The main purpose of this study is to learn if influenza vaccines (live attenuated and inactivated influenza vaccines), when given to school-aged children 4 to 18 years of age, can stop or lessen the influenza (flu) outbreak in the community. Another purpose is to show that vaccination of these child...
What is the current status of trial NCT00138294?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29,255 participants. The study started on 1998-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00138294?
The interventions under investigation include: live attenuated and inactivated influenza vaccines (BIOLOGICAL).
Who is sponsoring clinical trial NCT00138294?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.